Neurological Toxicity in Metastatic Colorectal Cancer Patients Treated with Modified FOLFOX6 Plus Bevacizumab

This study was conducted to investigate the toxicity and efficacy of modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer with particular regard to oxaliplatin-induced neuropathy. Toxicity was graded according to the National Cancer Institute Common Terminology Criteria fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsu, Satoshi, Hirashima, Yoshinori, Nishikawa, Kazuo, Sakashita, Hiroyuki, Morinaga, Ryotaro, Watanabe, Koichiro, Shirao, Kuniaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134004/
https://www.ncbi.nlm.nih.gov/pubmed/25210489
http://dx.doi.org/10.4137/JCM.S15553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134004/
https://www.ncbi.nlm.nih.gov/pubmed/25210489
http://dx.doi.org/10.4137/JCM.S15553

Ejemplares similares